Logo image of AL2SI.PA

2CRSI SA (AL2SI.PA) Stock Fundamental Analysis

Europe - EPA:AL2SI - FR0013341781 - Common Stock

9.06 EUR
-0.07 (-0.77%)
Last: 9/29/2025, 7:00:00 PM
Fundamental Rating

3

Taking everything into account, AL2SI scores 3 out of 10 in our fundamental rating. AL2SI was compared to 28 industry peers in the Technology Hardware, Storage & Peripherals industry. The financial health of AL2SI is average, but there are quite some concerns on its profitability. AL2SI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AL2SI has reported negative net income.
AL2SI had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: AL2SI reported negative operating cash flow in multiple years.
AL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFAL2SI.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

With a Return On Assets value of -8.34%, AL2SI is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -23.59%, AL2SI is doing worse than 67.86% of the companies in the same industry.
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROIC N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
AL2SI.PA Yearly ROA, ROE, ROICAL2SI.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

AL2SI's Gross Margin of 95.25% is amongst the best of the industry. AL2SI outperforms 100.00% of its industry peers.
AL2SI's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AL2SI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 95.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
AL2SI.PA Yearly Profit, Operating, Gross MarginsAL2SI.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

AL2SI does not have a ROIC to compare to the WACC, probably because it is not profitable.
AL2SI has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AL2SI has an improved debt to assets ratio.
AL2SI.PA Yearly Shares OutstandingAL2SI.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
AL2SI.PA Yearly Total Debt VS Total AssetsAL2SI.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AL2SI has an Altman-Z score of 4.65. This indicates that AL2SI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.65, AL2SI is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
AL2SI has a Debt/Equity ratio of 0.39. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AL2SI (0.39) is better than 60.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Altman-Z 4.65
ROIC/WACCN/A
WACC7.48%
AL2SI.PA Yearly LT Debt VS Equity VS FCFAL2SI.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

AL2SI has a Current Ratio of 1.69. This is a normal value and indicates that AL2SI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.69, AL2SI is doing good in the industry, outperforming 60.71% of the companies in the same industry.
A Quick Ratio of 1.08 indicates that AL2SI should not have too much problems paying its short term obligations.
The Quick ratio of AL2SI (1.08) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.08
AL2SI.PA Yearly Current Assets VS Current LiabilitesAL2SI.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

AL2SI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.98%, which is quite impressive.
The Revenue has decreased by -2.51% in the past year.
Measured over the past years, AL2SI shows a small growth in Revenue. The Revenue has been growing by 3.08% on average per year.
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%

3.2 Future

Based on estimates for the next years, AL2SI will show a very negative growth in Earnings Per Share. The EPS will decrease by -46.37% on average per year.
AL2SI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.16% yearly.
EPS Next Y2733.33%
EPS Next 2Y558.28%
EPS Next 3Y271.65%
EPS Next 5Y-46.37%
Revenue Next Year17.2%
Revenue Next 2Y34.67%
Revenue Next 3Y25.87%
Revenue Next 5Y14.16%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AL2SI.PA Yearly Revenue VS EstimatesAL2SI.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M
AL2SI.PA Yearly EPS VS EstimatesAL2SI.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 2026 2027 2028 0 0.5 1 1.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AL2SI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
AL2SI is valuated cheaply with a Price/Forward Earnings ratio of 6.77.
85.71% of the companies in the same industry are more expensive than AL2SI, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, AL2SI is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 6.77
AL2SI.PA Price Earnings VS Forward Price EarningsAL2SI.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AL2SI is valued a bit more expensive than the industry average as 67.86% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 83.71
AL2SI.PA Per share dataAL2SI.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

AL2SI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AL2SI's earnings are expected to grow with 271.65% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y558.28%
EPS Next 3Y271.65%

More info and screens

0

5. Dividend

5.1 Amount

AL2SI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

2CRSI SA

EPA:AL2SI (9/29/2025, 7:00:00 PM)

9.06

-0.07 (-0.77%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)03-24 2026-03-24
Inst Owners7.96%
Inst Owner ChangeN/A
Ins Owners50.9%
Ins Owner ChangeN/A
Market Cap202.31M
Analysts86
Price Target12.09 (33.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.21%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)49.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.77
P/S 1.13
P/FCF N/A
P/OCF N/A
P/B 7.08
P/tB 8.88
EV/EBITDA 83.71
EPS(TTM)-0.3
EYN/A
EPS(NY)1.34
Fwd EY14.78%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.01
BVpS1.28
TBVpS1.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.34%
ROE -23.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 95.25%
FCFM N/A
ROA(3y)-6%
ROA(5y)-4.94%
ROE(3y)-24.19%
ROE(5y)-19.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.01%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover2.21
Health
Industry RankSector Rank
Debt/Equity 0.39
Debt/FCF N/A
Debt/EBITDA 4.36
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.08
Altman-Z 4.65
F-ScoreN/A
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)93.52%
Cap/Depr(5y)80.3%
Cap/Sales(3y)1.3%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%192.84%
EPS Next Y2733.33%
EPS Next 2Y558.28%
EPS Next 3Y271.65%
EPS Next 5Y-46.37%
Revenue 1Y (TTM)-2.51%
Revenue growth 3Y3.08%
Revenue growth 5YN/A
Sales Q2Q%85.45%
Revenue Next Year17.2%
Revenue Next 2Y34.67%
Revenue Next 3Y25.87%
Revenue Next 5Y14.16%
EBIT growth 1Y76.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year609.09%
EBIT Next 3Y101.5%
EBIT Next 5Y51.49%
FCF growth 1Y-158.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-126.1%
OCF growth 3YN/A
OCF growth 5YN/A